State Street
ALXN

State Street’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,033,808
Closed -$1.84B 4752
2021
Q2
$1.84B Buy
10,033,808
+156,274
+2% +$28.7M 0.1% 197
2021
Q1
$1.51B Sell
9,877,534
-751,300
-7% -$115M 0.09% 230
2020
Q4
$1.66B Sell
10,628,834
-510,611
-5% -$79.8M 0.1% 181
2020
Q3
$1.27B Buy
11,139,445
+66,854
+0.6% +$7.65M 0.09% 217
2020
Q2
$1.24B Sell
11,072,591
-9,842
-0.1% -$1.1M 0.09% 209
2020
Q1
$995M Buy
11,082,433
+121,299
+1% +$10.9M 0.09% 212
2019
Q4
$1.19B Buy
10,961,134
+90,952
+0.8% +$9.84M 0.08% 239
2019
Q3
$1.06B Sell
10,870,182
-233,395
-2% -$22.9M 0.08% 249
2019
Q2
$1.45B Sell
11,103,577
-41,263
-0.4% -$5.4M 0.11% 195
2019
Q1
$1.51B Buy
11,144,840
+718,226
+7% +$97.1M 0.12% 180
2018
Q4
$1.02B Buy
10,426,614
+292,332
+3% +$28.5M 0.09% 218
2018
Q3
$1.41B Buy
10,134,282
+322,740
+3% +$44.9M 0.11% 185
2018
Q2
$1.22B Buy
9,811,542
+706,426
+8% +$87.7M 0.1% 197
2018
Q1
$1.01B Sell
9,105,116
-1,735,949
-16% -$193M 0.09% 239
2017
Q4
$1.3B Sell
10,841,065
-413,494
-4% -$49.4M 0.1% 200
2017
Q3
$1.58B Sell
11,254,559
-606,088
-5% -$85M 0.14% 155
2017
Q2
$1.44B Buy
11,860,647
+561,962
+5% +$68.4M 0.13% 172
2017
Q1
$1.37B Buy
11,298,685
+718,756
+7% +$87.1M 0.12% 176
2016
Q4
$1.29B Buy
10,579,929
+501,209
+5% +$61.3M 0.12% 181
2016
Q3
$1.24B Buy
10,078,720
+1,284,688
+15% +$157M 0.12% 173
2016
Q2
$1.03B Buy
8,794,032
+7,280
+0.1% +$850K 0.11% 195
2016
Q1
$1.22B Sell
8,786,752
-30,932
-0.4% -$4.31M 0.13% 162
2015
Q4
$1.68B Buy
8,817,684
+23,394
+0.3% +$4.46M 0.18% 115
2015
Q3
$1.38B Buy
8,794,290
+4,615
+0.1% +$722K 0.16% 133
2015
Q2
$1.59B Buy
8,789,675
+318,195
+4% +$57.5M 0.17% 128
2015
Q1
$1.47B Sell
8,471,480
-90,622
-1% -$15.7M 0.15% 142
2014
Q4
$1.58B Buy
8,562,102
+443,427
+5% +$82M 0.16% 135
2014
Q3
$1.35B Buy
8,118,675
+210,651
+3% +$34.9M 0.14% 151
2014
Q2
$1.24B Buy
7,908,024
+101,900
+1% +$15.9M 0.13% 172
2014
Q1
$1.19B Sell
7,806,124
-212,163
-3% -$32.3M 0.14% 164
2013
Q4
$1.07B Buy
8,018,287
+165,512
+2% +$22M 0.12% 186
2013
Q3
$912M Buy
7,852,775
+97,783
+1% +$11.4M 0.11% 188
2013
Q2
$715M Buy
+7,754,992
New +$715M 0.09% 215